XYDALBA

Endo Operations Ltd.🇨🇦 Health Canada

Approval Id: acccc66d122ce88a
Drug Approval Canada Name: XYDALBA
Product Name: XYDALBA
Status: Marketed
Status Date: 2021-05-28
Original Market Date: 2021-05-28
Din: 02480522
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 08:12.28.16
Atc Original: J01XA04 DALBAVANCIN
Atc Name: j 01 xa 04
Aig Number: 0160631001
Company Name: Endo Operations Ltd.
Company Address: 1st Floor, Minerva House, Simmonscourt Road, Ballsbridge, Dublin, Ireland, D04 H9P8

DALBAVANCIN (DALBAVANCIN HYDROCHLORIDE)

500 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

acccc66d122ce88a

Type

Standard